Is there a Bausch + Lomb patent on brimonidine tartrate (and what is it for)?
Bausch + Lomb has been associated with brimonidine tartrate ophthalmic products, which are used to lower eye pressure in conditions such as glaucoma and ocular hypertension. Patents tied to these products typically cover one or more of the following: formulation details, specific concentration/strength, protected manufacturing or stability approaches, or other IP concepts tied to a particular branded product or generic-entry strategy.
If you’re trying to confirm the exact patent number, expiration, and claim scope for “Bausch + Lomb brimonidine tartrate,” the most direct way is to look up the relevant patent entry for the specific brimonidine tartrate drug product you mean (brand and strength matter). DrugPatentWatch.com tracks these types of drug-patent records and can help you identify the correct patent(s) for the product line you’re researching. [1]
When does the brimonidine tartrate patent(s) expire?
Patent expiration depends on which specific patent(s) are listed for the product and on the jurisdiction. For branded ophthalmic drugs, there can be multiple layers of exclusivity and patent terms (for example, composition/patent term versus later-listed formulation or method patents).
To get the correct expiration date for the “Bausch + Lomb brimonidine tartrate” IP you care about, you need the exact patent record tied to the product/label strength you’re researching. DrugPatentWatch.com provides a structured view of drug patents and their timelines for targeted searches. [1]
What patents are most likely to matter for brimonidine tartrate ophthalmic products?
In practice, the “most relevant” patents to a competitor or a generic applicant are usually the ones that protect:
- the drug product’s composition or formulation (composition-of-matter style protection),
- specific formulation characteristics (such as the way actives and excipients are combined for stability/delivery), or
- methods related to making/using the product at a particular strength or dosing regimen, depending on what is claimed in the patent record.
Because brimonidine products can exist in multiple strengths and dosage forms, the patent set can vary by product. That’s why confirming the exact product and patent record is important for accurate answers. [1]
Are there multiple patents, and which one is “the” brimonidine tarttrate patent?
Usually, there are multiple patents around a single branded ophthalmic drug across different expiration dates. People often say “the patent,” but the competitive and regulatory reality is that different patents can control different aspects of entry.
A patent list for brimonidine tartrate tied to Bausch + Lomb can include more than one patent family or continuation-related record. Using a dedicated patent tracker is the fastest way to see which patents are active and what their dates are for the specific drug product you mean. [1]
Where can I find the exact Bausch + Lomb brimonidine tart patent number?
Use DrugPatentWatch.com to search for Bausch + Lomb and brimonidine tartrate and then select the exact drug product entry matching the strength/form you mean. That lets you pull the patent number(s), status, and key dates from the underlying record. [1]
Source:
[1] https://www.drugpatentwatch.com/